Translate this page to:
In JoVE (1)
Other Publications (1)
This translation into Turkish was automatically generated.
English Version | Other Languages
Articles by Raju C. Reddy in JoVE
Alerjen Bağlı Astım murin Modeli
Aravind T. Reddy, Sowmya P. Lakshmi, Raju C. Reddy
Department of Medicine, Division of Pulmonary, Allergy and Critical Care Medicine, Emory University and Atlanta VA Medical Center
Alerjik astım Deneysel fare modelleri hastalığı patogenezinde okuyan ve yeni ilaçlar geliştirmek için yeni olanaklar sunar. Bu modeller de alerjik immün yanıt, hava yolu inflamasyonu ve pulmoner patofizyolojisi yöneten ölçüm faktörleri için uygundur.
Other articles by Raju C. Reddy on PubMed
Constitutive Activation of Prosurvival Signaling in Alveolar Mesenchymal Cells Isolated from Patients with Nonresolving Acute Respiratory Distress Syndrome
American Journal of Physiology. Lung Cellular and Molecular Physiology. Mar, 2006 | Pubmed ID: 16214815
Acute respiratory distress syndrome (ARDS) is a clinical syndrome characterized by stereotypic host inflammatory and repair cellular responses; however, mechanisms regulating the resolution of ARDS are poorly understood. Here, we report the isolation and characterization of a novel population of mesenchymal cells from the alveolar space of ARDS patients via fiber-optic bronchoscopy with bronchoalveolar lavage (BAL). BAL was performed on 17 patients during the course of ARDS. Immunofluorescence staining and multiparameter flow cytometric analysis defined a population of alveolar mesenchymal cells (AMCs) that are CD45-/prolyl-4-hydroxylase+/alpha-smooth muscle actin+/-. AMCs proliferated in ex vivo cell culture for multiple passages; early passage (3-5) cells were subsequently analyzed in 13 patients. AMCs isolated from patients with persistent or nonresolving ARDS (ARDS-NR, n = 4) demonstrate enhanced constitutive activation of prosurvival signaling pathways involving PKB/Akt, FKHR, and BCL-2 family proteins compared with AMCs from patients with resolving ARDS (ARDS-R, n = 9). Exogenous transforming growth factor-beta1 markedly induces PKB/Akt activation in AMCs from ARDS-R. ARDS-NR cells are more resistant to serum deprivation-induced apoptosis compared with ARDS-R. This study identifies a novel population of mesenchymal cells that can be isolated from the alveolar spaces of ARDS patients. AMCs in patients with ARDS-NR acquire an activational profile characterized by enhanced prosurvival signaling and an antiapoptotic phenotype. These findings support the concept that apoptosis of mesenchymal cells may be an essential component of normal repair and resolution of ARDS and suggest that dysregulation of this process may contribute to persistent ARDS.